GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Long-Term Debt

TOWA Pharmaceutical Co (TSE:4553) Long-Term Debt : 円183,611 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Long-Term Debt?

TOWA Pharmaceutical Co's Long-Term Debt for the quarter that ended in Dec. 2023 was 円183,611 Mil.

TOWA Pharmaceutical Co's quarterly Long-Term Debt increased from Jun. 2023 (円167,829 Mil) to Sep. 2023 (円170,955 Mil) and increased from Sep. 2023 (円170,955 Mil) to Dec. 2023 (円183,611 Mil).

TOWA Pharmaceutical Co's annual Long-Term Debt increased from Mar. 2022 (円79,194 Mil) to Mar. 2023 (円150,314 Mil) and increased from Mar. 2023 (円150,314 Mil) to Mar. 2024 (円189,124 Mil).


TOWA Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for TOWA Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Long-Term Debt Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51,664.00 74,098.00 79,194.00 150,314.00 189,124.00

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150,314.00 167,829.00 170,955.00 183,611.00 189,124.00

TOWA Pharmaceutical Co  (TSE:4553) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


TOWA Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TSE:4553) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines